Martin Mrozek, DPM
Primary Podiatric Medicine · Fayetteville, WVNPI 1437119856
Payments from drug & device makers
Across 39 payments — averaging $17.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kowa Pharmaceuticals America, Inc.$158
- ANI Pharmaceuticals, Inc.$149
- Amgen$99
- Pfizer$55
- IBSA Pharma Inc.$53
- Advanced Oxygen Therapy Inc.$35
- plus $121 from 5 others
What the payments were for
- Food & beverage$671100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 16 | $158 |
| ANI Pharmaceuticals, Inc. | 2 | $149 |
| Amgen | 2 | $99 |
| Pfizer | 4 | $55 |
| IBSA Pharma Inc. | 3 | $53 |
| Advanced Oxygen Therapy Inc. | 5 | $35 |
| Nabriva Therapeutics, PLC | 2 | $35 |
| Organogenesis Inc. | 2 | $33 |
| Kerecis Limited | 1 | $22 |
| Vertex | 1 | $17 |
| Bioventus LLC | 1 | $15 |
How this compares
Too few primary podiatric medicine providers in West Virginiato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 188 | $2,268 |
| Lidocaine | 49 | $1,363 |
| CeftriaxoneCeftriaxone Sodium | 19 | $837 |
| Ammonium Lactate | 34 | $834 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 14 | $647 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 57 | $492 |
| Gabapentin | 57 | $332 |
| Mupirocin | 41 | $303 |
| Ketoconazole | 21 | $284 |
| Celecoxib | 14 | $181 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 27 | $132 |
| Cilostazol | 14 | $116 |
| Terbinafine Hcl | 12 | $86 |
| Duloxetine Hcl | 17 | $76 |
| Levofloxacin | 15 | $76 |
Paid to pharmacies, not to this prescriber.
Other primary podiatric medicine in Fayetteville
- Gerald ErskineRonceverte$6K
- John WhiteHurricane$480
- Matthew PolkBerkeley Springs$206
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.